A comparison between next-generation sequencing and ASO-qPCR for minimal residual disease detection in multiple myeloma

Abstract only 8601 Background: Although molecular CR in multiple myeloma (MM) can be assessed by allele-specific oligonucleotide (ASO)-PCR, this technique requires preparation of clonotype-specific primers for each individual which is laborious and time-consuming. The usage of the LymphoSIGHT method...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 31; no. 15_suppl; p. 8601
Main Authors Takamatsu, Hiroyuki, Murata, Ryoichi, Zheng, Jianbiao, Moorhead, Martin, Terasaki, Yasushi, Yoshida, Takashi, Faham, Malek, Nakao, Shinji
Format Journal Article
LanguageEnglish
Published 20.05.2013
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first